{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:07:33Z","timestamp":1775466453681,"version":"3.50.1"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,2,18]]},"DOI":"10.1001\/jama.2024.25640","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:32:48Z","timestamp":1737563568000},"page":"636","source":"Crossref","is-referenced-by-count":2,"title":["Risankizumab for Ulcerative Colitis"],"prefix":"10.1001","volume":"333","author":[{"given":"Peng","family":"Li","sequence":"first","affiliation":[{"name":"Beijing Hospital, National Center of Gerontology, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"11","key":"jle240166r1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jama.2024.12414","article-title":"Risankizumab for ulcerative colitis: two randomized clinical trials.","volume":"332","author":"Louis","year":"2024","journal-title":"JAMA"},{"issue":"10114","key":"jle240166r2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"jle240166r3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa2314585","article-title":"Risankizumab versus ustekinumab for moderate-to-severe Crohn\u2019s disease.","volume":"391","author":"Peyrin-Biroulet","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"jle240166r4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States.","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2829532\/jama_li_2025_le_240166_1738864658.81803.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:10:12Z","timestamp":1739895012000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2829532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.25640","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}